Which hedge funds own CLYM? CLIMB BIO INC, Q2 2026 13F holders
6 of the hedge funds tracked by WhaleCreep disclosed a position in CLYM (CLIMB BIO INC) in their Q2 2026 13F filings, worth $282.3m in total. The largest holder by portfolio weight is RA Capital Management at 2.0% of its book. 2 managers opened a new position this quarter: Woodline Partners, D. E. Shaw & Co. 3 exited: Brevan Howard Capital Management, Marshall Wace, Point72 Asset Management LP.
6tracked managers holding
2opened this quarter
3exited this quarter
Which hedge funds hold CLYM? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| RA Capital Management | Q2 2026 | 2.0% | $230.1m | 11,300,939 | 0% | held |
| Woodline Partners | Q2 2026 | 0.1% | $20.6m | 1,582,291 | – | new |
| Citadel Advisors | Q2 2026 | 0.0% | $16.9m | 1,297,972 | 276% | added |
| Millennium Management | Q2 2026 | 0.0% | $11.8m | 908,198 | -29% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $2.5m | 192,700 | -11% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $375.6k | 28,800 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.0% | $387.9k |
| Marshall Wace | 0.1% | $5.3m |
| Point72 Asset Management LP | 0.0% | $404.8k |
How has hedge fund ownership of CLYM changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $282.3m |
| Q1 2026 | 7 | $139.5m |
| Q4 2025 | 3 | $74.7m |
| Q3 2025 | 2 | $117.4m |
| Q2 2025 | 2 | $72.4m |
| Q1 2025 | 2 | $71.2m |
| Q4 2024 | 2 | $104.9m |
| Q3 2024 | 3 | $298.0m |
| Q2 2024 | 3 | $411.9m |
| Q1 2024 | 3 | $36.1m |
| Q4 2023 | 3 | $35.6m |
| Q3 2023 | 2 | $34.7m |
| Q2 2023 | 2 | $36.9m |
| Q1 2023 | 2 | $38.2m |
| Q4 2022 | 2 | $48.4m |
| Q3 2022 | 3 | $43.3m |
Counts every tracked manager that disclosed CLYM in that quarter's filing, including managers that have since stopped filing.